Medizinische Hochschule Hannover (MHH) / Hannover Medical School

University / College

Location: Hannover, Germany (DE)

ISNI: 0000000095299877

ROR: https://ror.org/00f2yqf98

Show on Map:

Publications

(1,478)

Research Grants

(4)

Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3 (2022) Arora P, Zhang L, Rocha C, Sidarovich A, Kempf A, Schulz S, Cossmann A, et al. Journal article Life style and Parkinson's disease (2022) Reichmann H, Csoti I, Koschel J, Lorenzl S, Schrader C, Winkler J, Wuellner U Journal article, Review article Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) Dorling L, Carvalho S, Allen J, Parsons MT, Fortuno C, Gonzalez-Neira A, Heijl SM, et al. Journal article Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 (2022) Arora P, Kempf A, Nehlmeier I, Graichen L, Schulz S, Cossmann A, Dopfer-Jablonka A, et al. Journal article, Editorial Impact on follow-up strategies in patients with primary sclerosing cholangitis (2022) Bergquist A, Weismueller TJ, Levy C, Rupp C, Joshi D, Nayagam JS, Montano-Loza AJ, et al. Journal article SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination (2022) Arora P, Kempf A, Nehlmeier I, Graichen L, Winkler MS, Lier M, Schulz S, et al. Journal article EXPECTATION AND ACCEPTANCE OF A CLINICAL DECISION SUPPORT SOFTWARE BY NEPHROLOGIST END-USERS: THE CKDNAPP SURVEY (2022) Kotsis FK, Beachle H, Altenbuchinger M, Meiselbach H, Kosch R, Sabine S, Tanja B, Schultheiss UT Conference contribution A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study) (2022) Grünwald V, Hilser T, Meiler J, Goebell P, Ivanyi P, Strauss A, Hartmann A, et al. Journal article Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: Phase IIIb LUCY final analysis (2022) Balmana J, Fasching P, Delaloge S, Park YH, Eisen A, Bourgeois H, Kemp Z, et al. Conference contribution Postponements in Use of Radiotherapy during the first Wave of the COVID-19 Pandemic? An Analysis of Hospital Data (2022) Kapsner L, Brunner T, Christiansen H, Kisser U, Mansoorian S, Prokosch HU, Seuchter S, et al. Conference contribution

‹ 1 ... 36 37 38 39 40 ... 148 ›